355 related articles for article (PubMed ID: 26254143)
1. Salivary and serum interleukin-6 levels in proliferative verrucous leukoplakia.
Bagan L; Sáez GT; Tormos MC; Labaig-Rueda C; Murillo-Cortes J; Bagan JV
Clin Oral Investig; 2016 May; 20(4):737-43. PubMed ID: 26254143
[TBL] [Abstract][Full Text] [Related]
2. Salivary and Serum Interleukin-6: A Credible Marker for Predicting Oral Leukoplakia and Oral Squamous Cell Carcinoma by Enzyme-Linked Immunosorbent Assay (ELISA).
Oshin M; Kulkarni PG; D SPR; Deepthi G; S KS; S JK
Cureus; 2024 Apr; 16(4):e59113. PubMed ID: 38803729
[TBL] [Abstract][Full Text] [Related]
3. Proliferative verrucous leukoplakia: high incidence of gingival squamous cell carcinoma.
Bagan JV; Jimenez Y; Sanchis JM; Poveda R; Milian MA; Murillo J; Scully C
J Oral Pathol Med; 2003 Aug; 32(7):379-82. PubMed ID: 12846783
[TBL] [Abstract][Full Text] [Related]
4. Proliferative verrucous leukoplakia and its related lesions.
Batsakis JG; Suarez P; el-Naggar AK
Oral Oncol; 1999 Jul; 35(4):354-9. PubMed ID: 10645398
[TBL] [Abstract][Full Text] [Related]
5. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
G D; Nandan SRK; Kulkarni PG
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
[TBL] [Abstract][Full Text] [Related]
6. Malignant transformation of proliferative verrucous leukoplakia to oral squamous cell carcinoma: a series of 55 cases.
Bagan JV; Jiménez-Soriano Y; Diaz-Fernandez JM; Murillo-Cortés J; Sanchis-Bielsa JM; Poveda-Roda R; Bagan L
Oral Oncol; 2011 Aug; 47(8):732-5. PubMed ID: 21683646
[TBL] [Abstract][Full Text] [Related]
7. Oral cancers preceded by proliferative verrucous leukoplakia exhibit distinctive molecular features.
Herreros-Pomares A; Hervás D; Bagan-Debon L; Proaño A; Garcia D; Sandoval J; Bagan J
Oral Dis; 2024 Apr; 30(3):1072-1083. PubMed ID: 36892444
[TBL] [Abstract][Full Text] [Related]
8. Whole genome DNA methylation and mutational profiles identify novel changes in proliferative verrucous leukoplakia.
Okoturo E; Green D; Clarke K; Liloglou T; Boyd MT; Shaw RJ; Risk JM
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Jun; 135(6):893-903. PubMed ID: 37088660
[TBL] [Abstract][Full Text] [Related]
9. Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancer.
Brailo V; Vucicevic-Boras V; Lukac J; Biocina-Lukenda D; Zilic-Alajbeg I; Milenovic A; Balija M
Med Oral Patol Oral Cir Bucal; 2012 Jan; 17(1):e10-5. PubMed ID: 21743397
[TBL] [Abstract][Full Text] [Related]
10. [Proliferative verrucous leukoplakia. Report of five cases].
Reichart PA; Philipsen HP
Mund Kiefer Gesichtschir; 2003 May; 7(3):164-70. PubMed ID: 12764683
[TBL] [Abstract][Full Text] [Related]
11. Potentially malignant disorders revisited-The lichenoid lesion/proliferative verrucous leukoplakia conundrum.
Thomson PJ; Goodson ML; Smith DR
J Oral Pathol Med; 2018 Jul; 47(6):557-565. PubMed ID: 29663518
[TBL] [Abstract][Full Text] [Related]
12. Salivary level of interleukin-8 in oral precancer and oral squamous cell carcinoma.
Punyani SR; Sathawane RS
Clin Oral Investig; 2013 Mar; 17(2):517-24. PubMed ID: 22526890
[TBL] [Abstract][Full Text] [Related]
13. Global gene expression profile of proliferative verrucous leukoplakia and its underlying biological disease mechanisms.
Farah CS; Shearston K; Turner EC; Vacher M; Fox SA
Oral Oncol; 2024 Apr; 151():106737. PubMed ID: 38408418
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus in oral proliferative verrucous leukoplakia and squamous cell carcinoma: A preliminary study.
Bagan JV; Jiménez Y; Murillo J; Poveda R; Díaz JM; Gavaldá C; Margaix M; Scully C; Alberola TM; Torres Puente M; Pérez Alonso M
Med Oral Patol Oral Cir Bucal; 2008 Feb; 13(2):E110-3. PubMed ID: 18223526
[TBL] [Abstract][Full Text] [Related]
15. Molecular landscape of proliferative verrucous leukoplakia: a systematic review.
Nissanka-Jayasuriya EH; Fenton TR; Rose-Zerilli MJJ
Br J Oral Maxillofac Surg; 2024 Feb; 62(2):118-127. PubMed ID: 38296711
[TBL] [Abstract][Full Text] [Related]
16. Proliferative verrucous leukoplakia: an elusive disorder.
Parashar P
J Evid Based Dent Pract; 2014 Jun; 14 Suppl():147-53.e1. PubMed ID: 24929599
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.
St John MA; Li Y; Zhou X; Denny P; Ho CM; Montemagno C; Shi W; Qi F; Wu B; Sinha U; Jordan R; Wolinsky L; Park NH; Liu H; Abemayor E; Wong DT
Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):929-35. PubMed ID: 15313862
[TBL] [Abstract][Full Text] [Related]
18. Salivary interleukin-6 in the detection of oral cancer and precancer.
Panneer Selvam N; Sadaksharam J
Asia Pac J Clin Oncol; 2015 Sep; 11(3):236-41. PubMed ID: 25560781
[TBL] [Abstract][Full Text] [Related]
19. Proliferative verrucous leukoplakia: a clinicopathological comparative study.
Alkan U; Bachar G; Nachalon Y; Zlotogorsky A; Levin EG; Kaplan I
Int J Oral Maxillofac Surg; 2022 Aug; 51(8):1027-1033. PubMed ID: 35065850
[TBL] [Abstract][Full Text] [Related]
20. Proliferative verrucous leukoplakia: a potentially malignant disorder involving periodontal sites.
Gandolfo S; Castellani R; Pentenero M
J Periodontol; 2009 Feb; 80(2):274-81. PubMed ID: 19186968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
